Pharma VC Funds

Polytech Ventures is a venture capital firm based in Switzerland, focusing on early-stage investments with a strong international outlook. The firm primarily invests in sectors like fintech, insurtech, healthtech, and proptech. Established in 2015, Polytech Ventures has offices in Lausanne, Switzerland, at the EPFL campus, and in San Francisco, USA, providing a bridge for European startups to access the Silicon Valley ecosystem. Polytech Ventures operates under the umbrella of Polytech Ecosystem Ventures, which combines the strengths of Swiss and European technological innovation with the market access and growth opportunities available in the United States. The firm has a $40 million fund aimed at supporting digital transformation across various industries, including fintech, insurtech, digital health, and retail tech. The fund's strategy involves identifying high-potential startups in Switzerland and Europe and helping them establish a presence in the US to accelerate their growth. Notable portfolio companies include Beekeeper, Saphetor, Inpher, BlueFox, and Weft. Polytech Ventures is committed to fostering innovation by providing both capital and strategic guidance to early-stage companies.

Pontifax Venture Capital is a healthcare-focused venture capital firm based in Herzliya, Israel, founded in 2004. The firm manages approximately $1.2 billion across multiple funds and focuses on identifying and investing in transformative life sciences technologies at all stages of development. Pontifax's portfolio includes around 100 companies that address significant unmet medical needs through groundbreaking innovations​. The firm was co-founded by Eli Hurvitz, a legendary figure in the pharmaceutical industry and former CEO of Teva Pharmaceuticals, alongside Ran Nussbaum and Tomer Kariv. Pontifax takes a hands-on approach with its portfolio companies, providing strategic guidance and leveraging extensive networks to help these companies grow and succeed. Pontifax's investment strategy spans various sectors within the life sciences, including biopharmaceuticals, medical devices, and gene therapy. Notable investments include Kite Pharma, which was acquired by Gilead Sciences, and Eloxx Pharmaceuticals, which focuses on treatments for genetic diseases caused by nonsense mutations.

Portal Innovations is a Chicago-based venture development engine that specializes in supporting early-stage life sciences, medtech, and bioinformatics startups. Founded by John Flavin, a seasoned entrepreneur with a strong track record in life sciences, Portal Innovations provides what it calls "Crafted Capital™," which includes seed funding, state-of-the-art lab space, and strategic management support. The firm operates in key U.S. biotech hubs, including Chicago, Atlanta, Boston, and Houston, offering over 80,000 square feet of lab and office space tailored to the needs of its portfolio companies. Portal Innovations has a unique approach that bridges scientific ideation through commercial proof of concept by leveraging strong ties with academic institutions and industry partners. This enables them to identify and nurture promising startups, particularly those emerging from university labs. Portal Innovations' portfolio includes a diverse range of companies such as Cardiosense, which is developing a digital biomarker platform, and ClostraBio, focused on new therapeutics for inflammatory bowel disease and food allergies. The firm’s recent expansion into Houston, in collaboration with the Texas Medical Center, highlights its commitment to growing the U.S. life sciences ecosystem by providing critical resources and support to early-stage companies​.

Portugal Ventures, founded in 2012, is a prominent venture capital firm in Portugal that focuses on early-stage investments. As part of the Portuguese promotional bank Grupo Banco Português de Fomento, Portugal Ventures aims to boost the country's entrepreneurial ecosystem by providing financial and strategic support to innovative startups. The firm has invested over €214.8 million since its inception, managing a diverse portfolio that spans various sectors, including technology, life sciences, and tourism. Notable investments include Farfetch, Principle Power, and Fyde. In 2022, Portugal Ventures invested €18.6 million in 42 startups, highlighting its commitment to fostering innovation despite economic uncertainties​. Portugal Ventures operates several investment initiatives such as Call INNOV-ID, which targets early-stage startups with developed technology but still in prototype or proof-of-concept phases. This initiative, in partnership with the National Innovation Agency, has seen significant success, investing €5.5 million in 55 startups across three editions. Other initiatives include Call Tourism and Call FIT, aimed at promoting innovation in tourism and fostering new technologies. The firm emphasizes co-investments and partnerships to strengthen its portfolio companies. In 2022, it made follow-on investments totaling €9.8 million in 25 companies, ensuring they have the capital to scale and thrive. Notable follow-on investments include Aptoide, Probely, and Didimo​

Position Ventures is an early-stage VC firm focused on helping startups sharpen their positioning and communications strategies. Founded by Jenny He, an experienced communications strategist, the firm prides itself on being a strategic partner that helps founders craft compelling narratives to cut through the noise. Position Ventures has backed notable companies like Twitch, Snapcommerce, Sleeper, and WorkWhile, with a particular interest in tech-driven startups across sectors like media, e-commerce, and software. Their strategy goes beyond just funding—they offer hands-on support with media relations, internal communication, and public launches. Founders often credit Jenny and her team for providing invaluable help in media training, securing coverage, and preparing for high-stakes launches. Position Ventures primarily invests in U.S.-based startups but takes a founder-centric approach, actively working alongside teams to refine their market positioning. They seek startups with clear storytelling potential and strong founder-market fit. The firm tends to participate in early-stage rounds, often providing lead investments with strategic support, though they don’t disclose average check sizes. Position Ventures prefers to be approached by founders who are clear on their brand's positioning and growth potential, favoring businesses that aim to stand out through effective narrative and media strategies.

Possible Ventures is an innovative venture capital firm based in Munich, Germany, dedicated to backing mission-driven teams using frontier technology to address significant global challenges. Founded by Chris Hitchen, who brings extensive experience from previous roles at EQT Ventures and Project A, the firm focuses on early-stage investments, particularly at the pre-seed and seed stages. The fund's investment strategy is centered on deep tech and techbio sectors, including AI, life sciences, climate tech, energy, cybersecurity, space tech, and dual-use technologies. Notable investments from their portfolio include successful companies like Sorare, Anydesk, Immutable, Cognigy, and Holidu, alongside deep tech innovators such as Marvel Fusion and ToZero. Possible Ventures typically writes checks ranging from €250k to €500k and often co-invests with a global network of over 200 entrepreneurial investors and 250 founders. Their approach involves a high level of engagement and support, providing startups not only with capital but also with strategic advice and connections to other value-added investors. The team at Possible Ventures includes key figures such as Dr. Christoph Baumeister, Marie Tai, and Thyra Seitz, who bring diverse expertise across various high-tech and bio-scientific fields. They prefer founders to approach them with clear, impactful technology solutions that align with their mission of solving humanity's biggest challenges. Possible Ventures has made a significant mark by maintaining a strong presence in both European and global markets, offering a robust support system for early-stage startups aiming to make a substantial impact.

Practica Capital is an early-stage venture capital firm dedicated to supporting Baltic founders in Lithuania, Latvia, and Estonia. With over €130 million in assets under management, Practica Capital focuses on investing in tech-driven companies at the seed, pre-seed, and Series A stages. Their portfolio includes notable startups like TransferGo, Eneba, CGTrader, and Trafi. The firm's investment strategy is characterized by active involvement in their portfolio companies, providing strategic guidance and leveraging a strong network of co-investors, including local and international VCs, accelerators, and angel investors. Practica Capital typically invests between €300k and €3M per round, aiming to partner with founders who exhibit strong ambition and innovative potential. The team at Practica Capital includes experienced professionals like Donatas Keras, Tomas Andriuškevičius, and Arvydas Bložė, who bring valuable industry insights and entrepreneurial experience to the table. For startups seeking investment, Practica Capital values clear, compelling pitches that demonstrate significant market potential and technological innovation. Their approach as an entrepreneurial and active investor positions them as a key player in the Baltic venture ecosystem, helping to drive the growth and success of tech startups in the region.

Praetura Ventures, founded in 2011 and based in Manchester, UK, is a venture capital firm that emphasizes offering "more than money" to early-stage businesses. Their focus is on supporting high-growth companies across various sectors including medtech, transport tech, retail tech, insurtech, and SaaS. Notable investments in their portfolio include ScubaTx, Seatfrog, Sparkbox, and Sprout AI, which span diverse industries from medical technology to AI-driven retail solutions. Praetura Ventures typically invests around £1.9 million per company and has £544 million in assets under management. Their approach involves not only providing capital but also offering strategic support through their operational partners who have extensive industry experience. This holistic support model helps startups navigate growth challenges effectively. The firm's leadership team includes co-founders David Foreman and Peadar O'Reilly, along with partners like Jonathan Prescott and Sam McArthur, who bring decades of experience in financial services and investment management. For entrepreneurs, Praetura Ventures values clear communication and innovative solutions that address significant market needs. Praetura Ventures is particularly active in the Northern UK region, supporting local startups and helping them scale through both capital investment and strategic guidance. They maintain a strong network of co-investors and partners to maximize the growth potential of their portfolio companies.

Precursor Ventures is a San Francisco-based venture capital firm founded in 2015 by Charles Hudson. The firm specializes in pre-seed and seed investments, focusing on long-term relationships with founders. Precursor Ventures invests primarily in B2B and B2C software applications and hardware across the United States, Canada, and Mexico​​. Some notable investments from Precursor Ventures include The Athletic, Betty Labs, and Intellimize. The firm has a diverse portfolio, backing over 300 companies and achieving significant exits, such as Ele.me (acquired by Alibaba) and Qunar (NASDAQ: QUNR). Their investment approach emphasizes supporting underrepresented founders and pioneering ideas in untapped markets​. The team at Precursor Ventures, led by Charles Hudson, includes experienced professionals like Marina Girgis and Ashtan Jordan. They bring a wealth of knowledge from various industries, including technology and finance. The firm's strategy revolves around providing substantial support to startups from the earliest stages of their development, helping them scale and grow​​. For startups seeking investment, Precursor Ventures values clear, compelling pitches that align with their focus on innovation and potential market impact. They prefer to build strong, supportive relationships with founders to ensure long-term success​

Predictive Venture Partners is a venture capital firm founded in 2019, specializing in early- and growth-stage investments in startups that leverage data-driven and predictive technologies. Based in North Andover, Massachusetts, Predictive VC focuses on sectors like artificial intelligence, fintech, analytics, and enterprise applications. The firm is highly selective, typically targeting innovative startups that demonstrate strong potential for scalability and societal impact. Predictive VC’s portfolio includes investments in companies like Mighty Health, a healthcare platform, and Pomelo, a financial software company. The firm often co-invests with other well-known funds, such as Insight Partners and Pareto Holdings, and has a growing track record of supporting companies from seed to later stages. They are particularly interested in ventures that harness data to create efficiencies and solve complex problems across industries like financial services, logistics, and digital health. The firm is led by Kevin Fung, who brings deep expertise in tech-driven investments. Predictive VC’s investment strategy emphasizes building long-term partnerships with founders, providing both capital and operational expertise to help startups scale. Although primarily focused on the U.S. market, the firm also invests in international startups with high growth potential. For startups seeking to engage with Predictive VC, demonstrating a strong market fit, a robust tech platform, and clear paths for growth is key to gaining attention.

Preface Ventures, founded in 2020 and headquartered in New York, focuses on early-stage investments in enterprise infrastructure and software startups. Preface Ventures typically invests between $500k to $2M in pre-seed and seed rounds, with follow-on investments ranging from $1M to $3M. They are known for being the first check in 80% of their investments, and often invest before companies even have a bank account​. Notable investments in their portfolio include companies like Leen, Knock, and Qpoint, reflecting their focus on network management and business productivity software. Preface Ventures has also seen successful exits with companies like Truebill and Remitly. The firm is led by Founder and General Partner Farooq Abbasi, who emphasizes a hands-on approach in the first 100 days of investment, helping startups build financial and board reporting infrastructure. Preface Ventures also assists in constructing seed syndicates, making key customer introductions, and supporting team building efforts​. By leveraging deep industry relationships and a focus on strategic support, Preface Ventures aims to help founders build enduring companies at the frontier of enterprise innovation.

Prelude Ventures, headquartered in San Francisco, is a leading venture capital firm focusing on climate tech investments. Since its inception in 2013, the fund has backed over 150 companies, emphasizing innovative solutions for carbon reduction and sustainability. Notable investments include QuantumScape, a leader in solid-state battery technology; Planet Labs, a satellite imagery provider; and Benson Hill, specializing in plant-based food ingredients. Prelude Ventures concentrates primarily on energy, food, agriculture, and resource optimization sectors, with a geographic focus predominantly in North America. Their investment strategy targets early to growth-stage companies that have the potential to significantly impact climate change. They prefer leading rounds and often provide substantial follow-on funding to support scaling. The fund’s average check size varies, typically ranging from $1M to $20M, depending on the stage and needs of the company. Prelude Ventures is known for being active and engaged investors, offering strategic guidance and leveraging their extensive network to support portfolio companies. Key team members include co-founders Gabriel Kra and Nathaniel Simons, and managing directors Mark Cupta and Matt Eggers. The team is based in San Francisco and is highly experienced in both investment and operational roles within the clean tech and sustainability sectors.

PreSeed Ventures, based in Kongens Lyngby, Denmark, is a prominent early-stage venture capital firm founded in 2000. The firm focuses on investing in startups within the life sciences, information technology, advanced manufacturing, and clean technology sectors, primarily in Denmark and Sweden. PreSeed Ventures has a diverse portfolio featuring companies like Trustpilot, an online review platform that went public in 2021, and Vivino, a popular online wine community platform. Other significant investments include Templafy, a template management platform, and Coinify, a crypto-based payment solution. The firm has also seen successful exits, such as Heyhack, acquired by F5 Networks, and Pento, a payroll automation service. The firm typically invests in seed and early-stage rounds, providing not only capital but also strategic support to help startups scale and achieve significant milestones. PreSeed Ventures is known for its commitment to fostering innovation and supporting ambitious entrepreneurs in building transformative companies.

Presidio Ventures, the corporate venture capital arm of Sumitomo Corporation, has been a significant player in the VC landscape since 1998. Based in Silicon Valley, Boston, and Los Angeles, Presidio Ventures focuses on early to growth-stage investments in enterprise IT, cybersecurity, AI, digital media, mobility, IoT, fintech, and robotics. Notable portfolio companies include Shapeways, Global Thermostat, and Falkonry, showcasing their broad investment scope. Presidio Ventures strategically supports startups with financial backing and business development expertise, leveraging Sumitomo's vast network to help these companies scale globally. Their investment strategy centers on identifying transformative technologies that address pressing global needs, from urbanization solutions to advancements in AI and digital media. The team, led by CEO Doug Kuribayashi, emphasizes collaboration with entrepreneurs to ensure success from early-stage investments to IPO. Their approach includes rigorous due diligence and a focus on scalable solutions with significant market potential. Presidio Ventures prefers detailed pitch decks that demonstrate innovative solutions and clear business models. Their expansive network and industry expertise make them a valuable partner for startups aiming to make a substantial impact in their respective fields.

Presight Capital, founded in 2019 by Christian Angermayer in partnership with Apeiron Investment Group, is a global venture capital firm based in West Hollywood, California. The firm manages over $600 million in assets across two early-stage funds and focuses on investing in biotechnology, consumer, fintech, deep tech, food tech, cryptocurrency, healthcare, and technology sectors. Notable investments by Presight Capital include ATAI Life Sciences, a mental health company using psychedelics; AbCellera, a biotech firm specializing in antibody therapies; and Compass Pathways, which focuses on mental health treatments using psilocybin. Other prominent companies in their portfolio are General Fusion, EnergyVault, and Perfect Day, which produces lab-grown dairy products. Presight Capital aims to support ambitious founders by providing capital, connections, and strategic advice. They invest in various stages, from seed to IPO, and have a diverse portfolio that includes companies like Razor Group, Syfe, and Alto Neuroscience. The firm's approach is characterized by a strong emphasis on transformative technologies and groundbreaking solutions across different industries​.

Prime Movers Lab is a venture capital firm dedicated to investing in breakthrough scientific startups that have the potential to transform major industries and impact billions of lives. Their diverse portfolio includes notable companies such as Boom Supersonic, which is developing supersonic airliners, and Axiom Space, which aims to build the first commercial space station. Other significant investments include Quantum Space, Lyten, and Heliogen, showcasing their focus on innovative technologies in aerospace, energy, and sustainable materials​. Prime Movers Lab primarily invests in early-stage companies, often leading funding rounds with substantial checks that can range significantly based on the needs of the startup. Their investment strategy emphasizes deep scientific and technological advancements that offer solutions to global challenges. They seek out companies with the potential for high growth and significant impact, preferring those that demonstrate strong scientific foundations and transformative potential. The firm is based in Jackson, Wyoming, and operates with a mission-driven approach, looking to partner with visionary founders who are committed to pushing the boundaries of innovation. Key team members include Dakin Sloss, the founder and general partner, who has a robust background in supporting transformative startups. Amy Kruse, a general partner, leads life sciences investments with expertise in neuroscience and synthetic biology. Prime Movers Lab is known for its hands-on approach, providing not just capital but also strategic support, mentorship, and access to a network of industry experts. This approach helps their portfolio companies accelerate their growth and achieve their ambitious goals.

Pritzker Group, founded by the Pritzker family, is a diversified investment firm with a robust portfolio spanning private capital, venture capital, and asset management. Their investment strategies leverage a permanent capital base, allowing for flexible, long-term investments without the constraints of traditional funding timelines. This approach benefits from the Pritzkers' extensive network, which includes access to advisors, strategic partners, and customers. Notable investments by Pritzker Group Venture Capital include high-profile companies such as Coinbase, SMS Assist, and SpotHero. The group focuses on sectors such as vertical SaaS, marketplaces, and healthtech, supporting companies from seed to growth stages. Their portfolio also includes companies like Cameo and G2 Crowd, showcasing their emphasis on innovative, scalable businesses. The private capital division of Pritzker Group focuses on acquiring and building leading middle-market companies in North America, with investments in industries like manufacturing, logistics, life sciences, and healthcare. Significant investments include firms like TMS International and STV Inc. Pritzker Group's asset management arm allocates capital globally to top-tier investment managers, providing diversified and strategic growth opportunities. Their comprehensive support for portfolio companies includes strategic guidance and leveraging their extensive network to accelerate growth and innovation​.

Privilège Ventures is a Swiss-based venture capital firm with a strong focus on early-stage investments across Europe, particularly in Switzerland, Italy, and Germany. Founded in 2016, Privilège Ventures is known for backing innovative startups in sectors like MedTech, DeepTech, and ICT. The firm is led by experienced partners, including Jacqueline Ruedin Rüsch and Angelica Morrone, who emphasize a hands-on, relationship-first approach to supporting founders. Privilège Ventures operates with a long-term vision, investing in companies that have the potential to make a significant positive impact on society. The firm recently launched a $20 million fund dedicated to investing in women-led startups, reflecting their commitment to fostering diversity within the entrepreneurial ecosystem. The portfolio includes notable companies like Distalmotion, AgroSustain, and Biospectal, and they have achieved successful exits with firms like Deliveroo and Creoptix. Privilège Ventures is distinguished by its deep entrepreneurial spirit, providing more than just capital but also strategic support and mentorship to help startups scale successfully.

Project A Ventures, founded in 2012 and based in Berlin, is a leading early-stage venture capital firm. The firm is renowned for its "operational VC" model, which goes beyond providing capital by offering extensive operational support through its team of over 140 functional experts. This team helps portfolio companies excel in areas such as tech, growth, data, and people. Project A focuses on sectors like fintech, digital health, logistics, eCommerce, proptech, B2B enterprise software, and mobility. They invest from pre-seed to Series A stages, with initial investments ranging from $1 million to $10 million, and reserves up to $30 million for future rounds. Their latest fund, which closed at $375 million, brings their total assets under management to $1 billion. Notable portfolio companies include Trade Republic, Kry, sennder, WorldRemit, Spryker, and Voi​.

Promus Ventures is a venture capital firm specializing in early-stage investments in deep-tech software and hardware companies. Founded in 2012, the firm has a global focus with offices in Chicago, San Francisco, and Luxembourg. Promus Ventures targets innovative sectors such as space technology, artificial intelligence, and advanced manufacturing. The firm has an impressive portfolio that includes notable companies like Rocket Lab, Mapbox, and Whoop. Rocket Lab, a leading space launch provider, and Whoop, a performance optimization wearable, are among their most successful investments, both achieving unicorn status. Promus Ventures also invests in companies like ICEYE, which operates the largest synthetic-aperture radar (SAR) satellite constellation. Promus Ventures' investment strategy emphasizes backing visionary and tenacious founding teams. They focus on transformative technologies with the potential to digitize mature industries and create significant market impact. Their approach involves close collaboration with portfolio companies, providing strategic guidance and leveraging their extensive network to support growth and scalability. The leadership team includes Mike Collett, based in Chicago, Pierre Festal in Luxembourg, and Gareth Keane in Santa Clara, each bringing extensive experience in technology and venture capital. The firm’s commitment to deep-tech and its global perspective make it a significant player in the venture capital landscape.

Propel(x), co-founded by Swati Chaturvedi and Lisheng Wang, is an online investment platform that connects science and technology startups with accredited investors. The platform focuses on deep tech startups in sectors such as energy, green technology, aerospace, life sciences, IT, communications, industrial technologies, and financial services. Notable investments facilitated through Propel(x) include Brelyon, which develops immersive display technology with backing from Lockheed Martin and the E14 Fund, and BlockApps, an enterprise blockchain platform supported by Morgan Creek and Liberty City Ventures. Repurpose, a company working to reduce single-use plastics, is another example, with investors like Chaifetz Group and SWAT Equity Partners. Ligandal, a biotech firm specializing in regenerative medicine and pandemic defense technology, also raised capital on the platform with support from Y Combinator and Techstars. Propel(x) offers Special Purpose Vehicles (SPVs) to pool funds, allowing investors to meet higher investment minimums. This approach democratizes access to early-stage investments in groundbreaking technologies. The platform ensures comprehensive due diligence and curated deal flow, providing investors with well-vetted startups. Propel(x) has been recognized for making early investment opportunities accessible to a broader range of investors.

PsyMed Ventures is a venture capital firm focused on transforming mental health treatment through innovative technologies, particularly in the areas of psychedelic medicine, neurotechnology, and precision psychiatry. Founded in 2020 by Dina Burkitbayeva, Greg Kubin, and Matias Serebrinsky, PsyMed Ventures began as a syndicate and has since evolved into a dedicated venture fund. In 2022, the firm launched a $25 million fund aimed at supporting early-stage startups that are pioneering new approaches to mental health. The fund's investments span a range of groundbreaking companies, including Freedom Biosciences and Delix Therapeutics, both of which are exploring the therapeutic potential of psychedelics. PsyMed's portfolio also includes companies working on advanced digital health platforms, novel drug formulations, and innovative neurotechnologies. PsyMed Ventures is particularly interested in companies at the pre-seed, seed, and Series A stages, believing that these early phases are where they can make the most significant impact. The firm emphasizes the importance of aligning with values-driven investors and entrepreneurs, recognizing that the mental health space requires long-term commitment and a collaborative approach.

Pureos Bioventures is a venture capital firm focusing on investing in innovative biopharmaceutical companies. Pureos Bioventures targets early-stage to growth-stage companies developing novel therapeutic approaches and technologies in the life sciences sector. The firm is particularly interested in startups that aim to address unmet medical needs and provide transformative treatments for patients. Pureos Bioventures is known for its strategic investments and active involvement in the development of its portfolio companies. The firm leverages its extensive network and deep industry expertise to support the growth and success of the startups it invests in. The investment strategy of Pureos Bioventures typically involves significant initial investments, with the potential for follow-on funding as companies progress. This approach allows the firm to nurture and support its portfolio companies through various stages of development, from early research to clinical trials and commercialization. The team at Pureos Bioventures comprises experienced professionals with backgrounds in biotechnology, pharmaceuticals, and venture capital. Their combined expertise enables them to identify promising investment opportunities and provide valuable guidance and support to their portfolio companies. For startups looking to engage with Pureos Bioventures, it is essential to demonstrate innovative and impactful therapeutic solutions with strong potential for clinical and commercial success. Emphasizing a clear path to address unmet medical needs and the potential for significant patient impact will be key in attracting investment from Pureos Bioventures.

Purple Orange Ventures (POV) is a Berlin-based, entrepreneur-led impact seed fund founded in 2012 by Gary Lin. Focused on leveraging science and technology, the fund is dedicated to solving some of the world’s most pressing challenges, specifically aiming to remove animals from the global food system and ensure sustainable food production. POV targets early-stage startups that are pioneering food-tech, agri-tech, and biotech innovations across the globe. POV invests primarily in pre-seed, seed, and Series A stages, with typical investments ranging from €100K to €1.5M. The fund backs mission-driven founders developing technologies in areas such as plant-based foods, lab-grown meat, and sustainable agriculture. Its portfolio includes companies like BLUU Seafood (lab-grown fish), Omni (plant-based pet food), and Change Foods (animal-free dairy). These startups are transforming the food industry by offering sustainable alternatives to traditional animal products. In addition to financial backing, Purple Orange Ventures provides its portfolio companies with business development support, operational expertise, and access to a network of industry experts to help accelerate growth and achieve market leadership. The firm’s mission reflects its commitment to creating a more sustainable, animal-free food ecosystem, positioning itself as a leader in the alternative protein and food technology sectors.

Pymwymic, founded in 1994, is a Netherlands-based impact investment cooperative that channels capital into businesses driving positive environmental and social change. Known for its pioneering role in European impact investing, Pymwymic's mission is to blend financial returns with measurable impact, focusing primarily on sectors such as sustainable agriculture, ecosystem restoration, and food systems. Their investments are managed through SDG-aligned sub-funds like the Healthy Food Systems Impact Fund, which targets startups transforming the global food industry through sustainable technologies. Over the years, Pymwymic has invested more than €60 million into innovative companies, helping them scale while maintaining their social missions. Recent investments include Aurea Imaging, which enhances environmental monitoring using AI, and Weenat, which focuses on data-driven water management​. With over 150 co-owners, Pymwymic operates as a cooperative, bringing together families, entrepreneurs, and institutional investors to co-develop impactful ventures. Their approach emphasizes impact governance, requiring companies to meet specific KPIs related to social and environmental outcomes. This community-driven structure allows Pymwymic to foster deep relationships with its portfolio companies, ensuring that the businesses stay committed to their missions as they grow and that profit never overshadows the planet​.

Qbic, established in 2012 and headquartered in St-Denijs-Westrem, Belgium, is a venture capital fund focused on early-stage investments, particularly in spin-offs from universities, research institutions, and hospitals. The fund supports startups in sectors such as deeptech, biotech, medtech, and software. Qbic has made significant contributions to transforming technological breakthroughs into sustainable businesses. Notable investments by Qbic include Theratrame, which focuses on cancer therapies, Animab, which develops alternatives to antibiotics for animals, and VoxelSensors, which specializes in 3D perception sensors for extended reality applications. Additionally, their portfolio includes companies like AmphiStar in the biotechnology field and Weave.ly in software development. Qbic manages around €200 million across its various funds, with Qbic III recently raising €88.5 million to continue supporting innovative spin-offs. The fund's strategic partners include major Belgian universities and research institutions, providing a strong pipeline of high-potential startups. The team at Qbic, led by Managing Partner Sofie Baeten, is dedicated to fostering technological innovation and supporting the growth of their portfolio companies.

Qiming Venture Partners, founded in 2006, is a leading venture capital firm with a strong focus on investments in the technology, consumer, and healthcare sectors. The firm operates with a significant presence in China and the United States, managing over $9.5 billion in capital across 18 funds. Qiming has an impressive portfolio of successful investments, including prominent companies such as Xiaomi, Bilibili, Meituan, and Mindray. These companies highlight Qiming's ability to identify and support high-potential startups that grow into industry leaders. The firm typically invests in early and growth-stage companies, emphasizing sectors like internet and consumer products, healthcare, and technology​​. The investment strategy at Qiming is comprehensive, often providing extensive support to portfolio companies through strategic guidance and leveraging a vast network. Key team members, like Bonnie Wang, focus on internet and consumer investments and have been recognized for their contributions to the venture capital industry​​. With a commitment to fostering innovation and growth, Qiming Venture Partners continues to play a crucial role in the global venture capital landscape, especially within the dynamic markets of China and the U.S.

Qiming Venture Partners USA, launched in 2017, focuses on early-stage investments in healthcare, particularly therapeutics and healthcare technologies, across the U.S. and Europe. Backed by its China-based parent firm Qiming Venture Partners, the U.S. arm leverages both financial and human capital to support transformative innovations in healthcare, including drug development and digital health solutions. With over $550 million raised across three funds, Qiming USA has already invested in more than 30 companies and achieved notable exits through M&A and IPOs. Their strategy is centered on partnering with visionary healthcare entrepreneurs, offering not just capital but also deep technical expertise and a global network, including synergies with the broader Qiming platform in China. Key team members include managing partners like Mark McDade and the recent addition of Isaac Ciechanover, whose extensive background in biotech strengthens Qiming’s healthcare focus. Their third fund, closed at $260 million in 2022, continues to invest in innovative therapeutics and health tech ventures that have the potential to make a significant impact on patient outcomes​.

Quake Capital, founded in 2016, is a venture capital firm and accelerator headquartered in Seattle, Washington, with a strong presence in New York and Los Angeles. The firm focuses on seed-stage investments, offering substantial support to new and early-stage ventures across a wide range of industries. Through their accelerator program, Quake Capital provides startups with resources, mentorship, and funding to help them grow and succeed. The firm has made over 300 investments in various sectors, including digital health, fintech, AR/VR, gaming, and e-commerce. Notable portfolio companies include NOCD, which offers online therapy for OCD; Blok Party, a platform combining physical, digital, and social play; Vyrill, a user-generated video content discovery and marketing platform; and Grain, which helps individuals build credit through savings. Quake Capital's investment strategy is industry-agnostic, emphasizing innovation and potential for growth. They typically invest $100,000 to $150,000 in each startup that completes their accelerator program. The firm’s founders, Glennon Argenbright, Chad Burgess, Adam Cragg, and Brandon Maier, bring extensive experience in venture capital and entrepreneurship, providing valuable insights and support to their portfolio companies.

Qualcomm Ventures, founded in 2000, is the corporate venture capital arm of Qualcomm Incorporated, headquartered in San Diego, California. The firm focuses on investing in early to growth-stage companies in sectors such as artificial intelligence (AI), automotive, mobile, enterprise and cloud, and smart systems. It supports startups with strategic guidance, leveraging Qualcomm’s extensive technological expertise and global network. Notable investments from Qualcomm Ventures include companies like Cloudflare, Xiaomi, Zoom, and SentinelOne. These companies have achieved significant milestones, including successful IPOs and high-profile acquisitions. For instance, SentinelOne went public in June 2021, and Zoom became a key player in cloud video conferencing and communication services. Qualcomm Ventures manages over $2 billion in assets and has a portfolio of more than 360 companies, with 22 unicorns and 19 companies that have gone public. The firm is also active in fostering innovation through specific funds like the Qualcomm Ventures AI Fund and the 5G Ecosystem Fund, which target emerging technologies in AI, machine learning, and 5G solutions. The investment team is composed of experienced professionals located in various global regions, including the US, China, and Israel, ensuring a broad and strategic reach to identify and support high-potential startups worldwide​.

Quantonation is a pioneering venture capital fund focused on early-stage investments in quantum technologies and deep physics. Founded in 2018, the Paris-based fund is dedicated to supporting startups working in quantum computing, quantum communications, quantum sensing, and related fields, aiming to accelerate the commercial adoption of groundbreaking scientific innovations. With over €91 million raised in its first fund, Quantonation has backed more than 30 companies, including notable names like Pasqal, ORCA Computing, and Qubit Pharmaceuticals. The fund's strategy targets startups at the pre-seed and seed stages, emphasizing those with the potential to transition quantum innovations into practical, industry-ready applications. These companies address critical areas such as molecular design, high-performance computing, and cybersecurity, with broader impacts expected in fields like healthcare, energy, and climate change mitigation. Quantonation leverages its deep scientific expertise and global network of research institutions, including partnerships with MIT, Ecole Polytechnique, and Oxford University. Quantonation has recently launched its second fund, Quantonation II, with a target of €200 million, signaling its commitment to expanding its support for quantum startups worldwide. Led by a team of experienced scientists and investors like Christophe Jurczak and Olivier Tonneau, the firm is actively shaping the future of the quantum tech ecosystem.

Quest Ventures is a leading venture capital firm focused on driving the digital economy across Asia. Founded in 2011 by James Tan and Wang Yunming, Quest Ventures invests primarily in early-stage startups within sectors such as artificial intelligence, e-commerce, fintech, logistics, media, and more. The firm is renowned for being one of the first investors in many startups, providing the critical early funding that enables these companies to scale and disrupt their industries. With its headquarters in Singapore and a significant presence in Southeast Asia, Quest Ventures has supported over 100 companies, including notable names like Carousell, ShopBack, 99.co, and StyleTheory. The firm's investment strategy includes thematic funds such as the Asia Fund, Metaverse Fund, and Decarbonisation Fund, focusing on areas like Web 3.0 technologies and environmental sustainability. Quest Ventures also operates investment syndicates, allowing accredited investors to participate in funding rounds of promising startups. This approach has enabled Quest Ventures to build a robust network of mentors, executives, and investors who provide strategic support and market insights to portfolio companies.

Quiet Capital, founded in 2017 and based in San Francisco, is a technology-focused venture capital firm. They invest in early-stage companies, spanning sectors such as fintech, software, cybersecurity, health and wellness, and AI. Their diverse portfolio includes notable companies like MoonPay, DuckDuckGo, Mercury, Reddit, and Substack. Quiet Capital typically invests from pre-seed to Series D stages, aiming to support remarkable founders from day zero. They have made 263 investments and achieved 11 notable exits, including Reddit and Atom Finance. Their investment strategy is centered on backing innovative technologies and scalable business models across a variety of industries. The firm is managed by a team of experienced partners including Ben Mahdavi, Co-Founder and Managing Partner, and Christopher Capozzi, Partner and CFO. They are known for their hands-on approach, providing strategic support and leveraging their extensive network to help portfolio companies grow. For startups looking to engage with Quiet Capital, demonstrating strong innovation, scalability, and a clear market need is essential. Connecting through their network or via their platform can improve the chances of securing investment.

R/GA Ventures is the investment and innovation arm of R/GA, a global digital agency. Founded in 2013, the firm supports early-stage startups through accelerator programs and offers financial, creative, and relationship capital. Notable investments include Latch, Happy Returns, and Transmit.Live. R/GA Ventures focuses on sectors such as IoT, commerce, retail, marketing tech, sports, and media tech. Their unique approach includes connecting startups with R/GA's extensive global network, providing strategic guidance and resources to help startups scale and succeed.

R42 Group is a venture capital firm based in Stanford, California, with a focus on deep science, artificial intelligence, and biotechnology. Established by Dr. Ronjon Nag, a seasoned AI entrepreneur with exits to companies like Motorola and Apple, R42 primarily invests in early-stage companies and supports them through a unique combination of financial backing and expert advisory. R42 has a hands-on approach, working closely with founders from the concept stage to growth, helping them build sustainable, impactful businesses in emerging fields such as AI, longevity, and deep tech. R42's portfolio includes companies such as Fountain Therapeutics, Healx, and Rubedo Life Sciences, all of which are innovating within the biotech and life sciences spaces. The firm also invests in early-stage funds that align with its values and frequently co-invests alongside these funds in promising startups. With a strong team of experts, including academics and industry veterans, R42 provides more than just capital—it offers strategic guidance, mentorship, and deep technical expertise to help companies succeed in highly specialized markets. In addition to investing, R42 runs the R42 Institute, which focuses on educating entrepreneurs and the broader community on AI, biotechnology, and longevity. Through its educational programs and investment strategies, R42 is committed to shaping the future of science and technology​.

RA Capital Management is a Boston-based venture capital and investment firm focused primarily on healthcare and life sciences. Founded in 2002, the firm invests across multiple stages, from seed funding to IPO, in companies developing drugs, medical devices, diagnostics, and research tools. RA Capital is known for its deep scientific and market expertise, facilitated by its internal research division, TechAtlas, which provides insights into competitive landscapes and helps guide investment decisions. The firm supports startups through its RAVen incubator, offering resources beyond capital, including strategic guidance, technology transfer, and executive recruitment. RA Capital has a strong commitment to innovation in human health, working closely with academics, entrepreneurs, and executives to bring groundbreaking therapies and technologies to market. Some notable portfolio companies include Moderna, Natera, and Peloton Therapeutics. RA Capital’s approach emphasizes evidence-based investing, focusing on creating value through informed decision-making and long-term growth.

Raba Capital, also known as The Raba Partnership, is a venture capital firm focused on early-stage investments in software and internet companies within the African technology ecosystem. Established in 2019 and headquartered in Cape Town, South Africa, Raba Capital aims to partner early with founders to help them build companies that solve real-world problems and generate significant returns. Notable investments in their portfolio include Flutterwave, a payment processing solution that became a unicorn in 2021, and Yoco, a merchant payments platform based in South Africa. Other significant investments include Lori Systems, a logistics marketplace, and Twiga, a digital grocery platform. Raba Capital focuses heavily on fintech, logistics, and healthcare sectors. They have invested in companies such as Stitch, which provides API infrastructure for fintechs, and 54gene, which leverages African DNA for medical discoveries. The firm prides itself on aligning long-term interests with their partners and leveraging their extensive network to support portfolio companies in scaling their businesses globally.

Rachel Zoe Ventures is an early-stage venture capital firm with a focus on disruptive consumer brands and the technologies that enable them. Led by fashion icon and entrepreneur Rachel Zoe, alongside her husband Rodger Berman, the firm leverages their vast experience in the media, fashion, and tech industries to help innovative consumer startups thrive. The firm is highly involved in amplifying the brands it backs, providing not just capital but also access to a vast network and strategic guidance on scaling brand recognition and growth. The firm has made key investments in brands such as Angel City FC, Joy, Havenly, and Citizen, all of which represent the type of forward-thinking, consumer-oriented companies Rachel Zoe Ventures seeks. Their portfolio demonstrates a strong emphasis on fashion, lifestyle, and tech-enabled consumer platforms. While primarily U.S.-focused, their influence and partnerships extend globally, especially in the consumer tech space. Rachel Zoe Ventures typically leads early-stage rounds and prefers to work with brands that are ready to scale their operations and disrupt their industries. The firm’s approach prioritizes partnerships with brands that align with its founders’ expertise in fashion, lifestyle, and media. Startups looking to engage with the firm should come prepared with a clear growth story and a compelling narrative that can stand out in today’s crowded consumer market.

Radical Ventures is a venture capital firm specializing in AI-driven startups that are poised to reshape various industries. Founded by AI pioneers, the firm is headquartered in Toronto with additional offices in Palo Alto, London, and New York. Radical Ventures focuses on investing in early-stage companies that leverage artificial intelligence to create transformational solutions. Their portfolio includes innovative companies like Waabi, which is developing next-generation self-driving technology, and Cohere, which works on advanced natural language processing. Other notable investments include Aspect Biosystems in biotechnology, ClimateAi for climate planning, and Signal 1, which provides real-time insights to healthcare providers. Radical Ventures emphasizes supporting their portfolio companies through the Radical Velocity program, which offers curated resources, expert support, and strategic partnerships to help AI-first startups scale effectively. This program covers areas such as talent acquisition, compute and technology needs, brand and public affairs, go-to-market strategies, and finance and governance. The firm's mission is to support founders who understand the profound impact AI will have on the future, aiming to drive significant advancements in sectors like healthcare, transportation, financial services, and more.

Radicle Growth, now operating as Clay Capital, is a venture capital firm focused on early-stage investments in agriculture and food technologies. Founded in San Diego, California, Radicle Growth aims to identify and support innovative entrepreneurs and technologies that can transform the food system. They frequently collaborate with global industry leaders to host challenges that fund groundbreaking agtech and foodtech startups. Notable investments by Radicle Growth include MycoTechnology, BlueNalu, Pluton Biosciences, and Phospholutions. MycoTechnology, a pioneer in fungal fermentation, won the $1 million growth-stage investment in the Radicle Protein Challenge by Syngenta. BlueNalu, focused on cell-based seafood, secured a $250,000 early-stage investment in the same challenge. Pluton Biosciences and Phospholutions were the winners of the Radicle Carbon & Soil Challenge by UPL, receiving $1 million and $250,000 respectively, to advance their innovative solutions in carbon sequestration and sustainable phosphorus use. Radicle Growth’s strategy involves not only funding but also providing startups with access to their extensive network of agriculture experts and global connections to accelerate development and promote their technologies. The firm’s commitment to sustainable agriculture is reflected in its continuous efforts to drive innovation and support the development of climate-positive solutions in the food value chain.

Raed Ventures is a leading early-stage venture capital firm based in Saudi Arabia, focusing on transformative tech startups across the MENA region. Established in 2015 by Omar Almajdouie and Talal Alasmari, the firm aims to back companies that disrupt traditional industries with innovative technologies. Raed Ventures’ portfolio includes over 20 fast-growing startups, such as Mrsool, Foodics, and Trella, spanning sectors like logistics, fintech, and data analytics. Raed Ventures actively leads seed and Series A rounds, particularly favoring businesses with scalable tech solutions. Their strategy goes beyond funding; they offer extensive operational support through the Raed Plus platform, providing startups with access to partnerships, discounted services, and expert advisory, saving founders up to $400,000 in costs. The firm is particularly keen on startups that drive financial inclusion, digital transformation, and operational efficiencies across industries in MENA. With an average check size undisclosed, Raed Ventures focuses on companies with strong founding teams and market potential. They are a go-to VC for entrepreneurs looking to gain traction in the region, thanks to their hands-on approach, deep industry connections, and expertise in scaling businesses. Founders looking to approach Raed Ventures should come with a clear vision for regional growth and technological impact. Key figures include Omar Almajdouie, who leads with over 17 years of experience, and Talal Alasmari, known for his expertise in team building and product design. Raed Ventures operates primarily out of Riyadh, making it a cornerstone in the Saudi and wider MENA tech ecosystem.

Rainfall Ventures is a founder-focused venture capital firm with a strong presence in New York and Los Angeles. Founded in 2011, the firm emphasizes partnering with innovative and passionate founders to help them transform industries. Rainfall Ventures typically invests in early-stage companies, including pre-seed, seed, and Series A rounds, with investment sizes ranging from $1 million to $5 million​. The firm focuses on a broad range of sectors such as analytics, AI, cloud infrastructure, social media, cryptocurrency, cybersecurity, developer tools, digital health, education, fintech, gaming, IoT, and more. This diverse investment strategy allows Rainfall to support a variety of technological advancements and innovative business models. Rainfall Ventures has a portfolio that includes notable companies like Kyra and Blloc, and they invest globally with a particular focus on the US and the UK. The firm has built a reputation for not only providing capital but also offering extensive support to their portfolio companies through mentorship and strategic guidance. The team at Rainfall Ventures includes experienced professionals like co-founder and General Partner Ron Rofé, who bring a wealth of knowledge and expertise to their investment strategy.

Rally Ventures, founded in 2012, is a venture capital firm focused on early-stage investments in business technology. The firm operates out of Menlo Park, California, and Minneapolis, Minnesota. Rally Ventures invests in entrepreneurs creating new markets or bringing transformative approaches to existing ones, with a particular emphasis on sectors like AI/ML, cybersecurity, fintech, and SaaS+. Rally Ventures has a robust portfolio of notable investments, including companies like Arctic Wolf, Bugcrowd, Harness, UiPath, Total Expert, Braze, Carbon Black, and Twistlock. These companies represent Rally Ventures' strategic focus on high-potential business technology ventures that can drive significant market impact. The firm recently closed Rally Fund V at $240 million, continuing its legacy of investing in innovative early-stage startups. Rally Ventures has built a nationwide portfolio with over $1 billion in assets under management and a strong track record of successful exits, including three IPOs. The team at Rally Ventures includes a dynamic group of over 100 Rally Tech Partners—executives, technologists, and industry leaders—who provide strategic guidance and operational support to portfolio companies. This extensive network helps Rally Ventures offer significant value beyond just financial investment.

Rapid Pioneers is a venture capital and investment firm based in Berlin, Germany, focused on building and investing in innovative consumer brands that shape the future. They have a diverse portfolio that includes companies across sectors like e-commerce, technology, and sustainability. Some of their key investments include Enpal, a leader in solar power solutions, and Animoca Brands, a Hong Kong-based venture capital firm specializing in web3 technologies. They have also backed companies like Lesara, an agile fashion retail brand, and Amorelie, a premium online brand for intimate products. Rapid Pioneers supports companies from early stages, helping them scale through strategic partnerships and hands-on involvement. They tend to invest in businesses with high growth potential in both the digital and physical goods spaces. Their portfolio highlights a strong focus on digital innovation, with investments in mobile apps, blockchain technology, and direct-to-consumer brands. The firm has made several successful exits, including Fitvia, a direct-to-consumer wellness brand, and Casacanda, a home décor e-commerce platform that was acquired by Fab.com. Rapid Pioneers emphasizes sustainability and innovation, working with brands that have a community-first approach and a vision for a greener, tech-driven future.

Rarestone Capital is a Web3-focused venture capital and investment studio that specializes in supporting innovative blockchain projects. The firm plays an active role in backing startups within the decentralized finance (DeFi), gaming, and NFT spaces, leveraging its deep industry knowledge and resources to accelerate the development of these groundbreaking technologies. Rarestone takes an incubation-first approach, offering more than just capital—it provides hands-on support through Rarestone Labs, where startups can access strategic guidance, technical expertise, and a robust network of partners and advisors. Some of the notable projects in Rarestone’s portfolio include Biconomy, Injective Protocol, and Jito Network, all of which are trailblazers in the blockchain ecosystem. Rarestone is known for investing early, often leading seed and Series A rounds, and focusing on founders with a clear vision for decentralized technologies. Their portfolio companies typically work at the intersection of crypto infrastructure and user-centric applications, aiming to make blockchain technology more accessible and scalable. Based in the UK, Rarestone has a global reach, with a particular focus on projects that drive adoption of Web3 technologies. The firm is highly selective and prefers founders who are not only technically skilled but also capable of executing disruptive ideas within the Web3 space. Startups looking to partner with Rarestone should demonstrate strong technical innovation and a clear roadmap for scaling within the blockchain ecosystem.

Real Ventures is Canada’s leading early-stage venture capital firm, dedicated to supporting visionary founders from the very beginning of their entrepreneurial journey. Established in 2007, Real Ventures has invested in more than 200 startups across various sectors, particularly focusing on technology-driven industries. Their portfolio features high-growth companies like Clearco, Mejuri, and BenchSci, which reflect the firm’s commitment to empowering disruptive innovations. The firm focuses primarily on Canadian startups but also supports global growth. They invest in pre-seed to Series A rounds and are deeply involved in nurturing the founders they back. Real Ventures is also known for fostering ecosystems where their portfolio companies can thrive, including co-founding Montreal’s Notman House, a hub for tech entrepreneurs. Their strategy emphasizes conscious leadership, encouraging founders to develop their mindsets as they grow their businesses. The firm’s FounderFuel accelerator program further bolsters this approach by providing startups with mentorship, resources, and community support. Founders approaching Real Ventures should demonstrate not only business potential but also a commitment to making a positive societal impact. Key figures include founding partners John Stokes, Alan MacIntosh, and JS Cournoyer, all experienced entrepreneurs and investors who are deeply embedded in Canada’s startup ecosystem. Through hands-on involvement, Real Ventures helps founders build lasting companies with the potential to reshape industries and improve the world.

Real Tech Fund, established in 2015 and headquartered in Tokyo, Japan, is a venture capital firm focusing on seed and early-stage investments in deep tech companies. The fund primarily targets sectors such as high tech, aerospace, AI, life sciences, and IoT. Real Tech Fund is known for its strategic partnerships with organizations like the Ministry of Economy, Trade, and Industry, and NEDO (New Energy and Industrial Technology Development Organization), aiming to solve critical societal and environmental issues through innovation. The fund's notable investments include companies like ArkEdge Space, which focuses on satellite communication and space travel, and Integriculture, an agricultural technology firm. Real Tech Fund has invested heavily in Japan, but also extends its reach to other regions, including Southeast Asia. The firm has an average investment round size of $4 million and typically leads or co-invests in 8-10 deals per year. The team at Real Tech Fund comprises experienced partners such as Mitsuru Izumo and Jonathan Hannam, who bring a wealth of expertise in various tech and investment domains. Real Tech Fund's investment approach emphasizes supporting companies that leverage advanced technology to create impactful solutions for society​.

Red Cedar Ventures is the venture investment subsidiary of the Michigan State University (MSU) Foundation. It focuses on providing early-stage funding to startups emerging from MSU’s research and entrepreneurial ecosystem, as well as other high-tech companies in Michigan. With the aim of driving economic impact in the region, Red Cedar Ventures supports innovation by helping to bridge critical funding gaps for startups, offering both pre-seed and growth-stage investments. The firm manages several funds, including a Pre-Seed Fund, Opportunity Fund I and II, and Michigan Rise Pre-Seed Fund III. These funds target startups at different stages of development, providing them with the capital needed to scale. Red Cedar Ventures also partners closely with Spartan Innovations and supports the Conquer Accelerator program, offering selected startups access to investment, mentorship, and resources to help them grow beyond the early phases. The firm’s investments span a wide range of industries, from AI to healthcare and cybersecurity, supporting startups like DeepView (smart cameras for factory inspections) and Flightpath Biosciences (therapies for pathogen-based diseases). With its roots in MSU, Red Cedar Ventures plays a key role in fostering innovation and entrepreneurship throughout Michigan.

Red Sea Ventures is a New York-based venture capital firm that focuses on early-stage investments. They primarily invest in technology-driven companies across sectors such as consumer products, fintech, healthtech, and real estate tech. Notable portfolio companies include Coinbase, Warby Parker, and Sweetgreen, showcasing their commitment to innovative and disruptive startups. Red Sea Ventures emphasizes a hands-on approach, working closely with founders to provide strategic guidance and operational support. They typically participate in Seed and Series A rounds, often leading these investments with check sizes ranging from $500k to $5 million. Their goal is to back visionary entrepreneurs who have the potential to build scalable businesses. Founded by Scott Birnbaum, Red Sea Ventures prides itself on a team of experienced professionals who bring a mix of entrepreneurial, operational, and investment expertise. They focus on the U.S. market, with a particular interest in the vibrant startup ecosystem of New York City. Entrepreneurs seeking investment from Red Sea Ventures are encouraged to have a clear and compelling business plan that demonstrates significant market opportunity and potential for growth. Warm introductions and referrals are preferred when approaching the firm, as they value strong, trusted networks.

Red Tree Venture Capital is a prominent West Coast-centric, early-stage life science venture firm founded in 2020 by Heath Lukatch, Ph.D., and Jennifer Cochran, Ph.D., with managing director Jon Edwards, Ph.D. The firm raised $272 million for its inaugural fund in 2022, focusing on groundbreaking therapeutics in oncology, neurology, and immunology​. Red Tree's notable investments include Acrigen Biosciences, Alladapt Immunotherapeutics, and Ceribell, all leading innovators in gene editing, immunotherapies, and neuromodulation technologies. The firm’s strategy leverages deep relationships with top West Coast academic institutions, including Stanford and UCSF, to source pioneering scientific advancements. Red Tree predominantly leads or co-leads investment rounds, emphasizing first-in-class and best-in-class therapeutics. The firm’s leadership team, with over 60 years of combined experience, is well-versed in translating scientific innovations into successful businesses. They are supported by a scientific advisory board comprising academic luminaries and experienced biopharma executives. The firm’s investment approach is built on four pillars: a focus on West Coast innovation, early-stage investments, targeting transformative therapeutics, and concentrating on oncology, neurology, and immunology. This strategic framework positions Red Tree as a key player in advancing life science innovations that have the potential to significantly impact patient care​.